Join CBSET at the MDG Boston forum, Funding your Medical Device Startup, March 3, 2020, at Draper Laboratories Auditorium, Fine Art Center, Hill Bldg, 1 Hampshire St., Cambridge, MA.
Medical device startup entrepreneurs will present each company’s value propositions and fundraising efforts to an expert panel. Following each presentation, the panel will discuss each company’s funding efforts and provide guidance to help it sharpen its plan.
If you would like to meet up with us there, please contact us.
Related CBSET Services:
- CBSET GLP Preclinical Services
- Localized/Targeted Drug Delivery
- Computational Modeling of Local Drug Delivery
- Cell-Based Therapies
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings. Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release. Volume 274, 28 March 2018, Pages 102-108
Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis. Abraham R. Tzafriri, Fernando Garcia-Polite, Brett Zani, James Stanley, Benny Muraj, Jennifer Knutson, Robert Kohler, Peter Markham, Alexander Nikanorov, Elazer R. Edelman. Journal of Controlled Release, Volume 264, 28 October 2017, Pages 203-210.
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Biomaterials: A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials. 2016 Jul;93:71-82. doi: 10.1016/j.biomaterials.2016.03.044.